文献速递其他结缔组织病

系统性硬化症成纤维细胞中GLI2/Hedgehog与转录因子JUN/AP-1信号通路的相互放大:联合治疗的潜在意义

Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies.
PubMed 文献 · Arthritis Rheumatol · 2024-10-20

该研究在弥漫性系统性硬化症(SSc)患者与健康志愿者的培养成纤维细胞和皮肤切片中,用敲低和药理方法抑制cJUN/AP-1与Hedgehog/GLI2信号,并在小鼠中成纤维细胞特异性过表达组成性激活的Smoothened以激活Hedgehog信号。结果显示cJUN与GLI2在SSc成纤维细胞中共上调并共定位,两条通路在转录水平相互诱导,联合抑制cJUN/AP-1与Hedgehog/GLI2在TGFβ驱动实验性纤维化模型中产生叠加抗纤维化效应。

要点

  • cJUN与GLI2在SSc患者成纤维细胞中共上调并共定位,二者在转录水平相互诱导。
  • 抑制cJUN/AP-1信号可改善SmootACT小鼠中Hedgehog诱导的成纤维细胞活化和皮肤纤维化,治疗组皮肤厚度较纤维化对照组减少103%(P=0.0043)。
  • 联合药理抑制cJUN/AP-1与Hedgehog/GLI2在TBRACT小鼠模型中产生叠加抗纤维化效应。

核心结论

  • 转录因子cJUN与GLI2相互增强活性以促进SSc中的成纤维细胞活化。
  • 联合抑制两条通路以阻断此交互作用,在耐受良好的剂量下产生叠加抗纤维化效应。

研究设计与样本

  • 研究分析弥漫性SSc患者与健康志愿者的培养成纤维细胞和皮肤切片。
  • 采用敲低和药理方法抑制cJUN/AP-1信号与Hedgehog/GLI2信号。
  • 通过成纤维细胞特异性过表达组成性激活的Smoothened在小鼠中激活Hedgehog信号。

主要发现

  • 与健康对照相比,cJUN与GLI2在SSc患者成纤维细胞中共上调并共定位。
  • 激活Hedgehog/GLI2信号在体外和体内诱导cJUN表达,而失活GLI2抑制cJUN表达。
  • 失活cJUN同样损害GLI2表达,此相互调控发生在转录水平,cJUN与GLI2结合于特定结合基序。
  • 在SmootACT小鼠中,抑制cJUN/AP-1信号改善Hedgehog诱导的成纤维细胞活化和皮肤纤维化,治疗组皮肤厚度较纤维化对照组减少103%(P=0.0043)。
  • 在TGFβ驱动的实验性纤维化模型(TBRACT小鼠)中,联合药理抑制cJUN/AP-1与Hedgehog/GLI2产生叠加抗纤维化效应。

关键数值与推荐

  • SmootACT小鼠中,抑制cJUN/AP-1信号后治疗组皮肤厚度较纤维化对照组减少103%(P=0.0043)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deregulation of the cJUN/AP-1 and hedgehog/GLI2 signaling pathways has been implicated in fibroblast activation in systemic sclerosis (SSc). However, the consequences of their concomitant up-regulation are unknown. Here, we tested the hypothesis that mutual amplification of both pathways might drive persistent fibroblast activation. METHODS: Cultured fibroblasts and skin sections of patients with diffuse SSc and healthy volunteers were analyzed. cJUN/AP-1 signaling and hedgehog/GLI2 signaling were inhibited using knockdown and pharmacologic approaches. Hedgehog signaling was activated in mice by fibroblast-specific overexpression of constitutively active Smoothened. RESULTS: cJUN and GLI2 are concomitantly up-regulated and colocalize in fibroblasts of patients with SSc compared to healthy controls. Activation of hedgehog/GLI2 signaling induces the expression of cJUN in vitro and in vivo, whereas inactivation of GLI2 inhibits cJUN expression. Likewise, inactivation of cJUN impairs the expression of GLI2. This mutual regulation occurs at the level of transcription with binding of cJUN and GLI2 to specific binding motifs. Interference with this mutual amplification of cJUN signaling and GLI2 signaling inhibits fibroblast activation and collagen release: Inhibition of cJUN/AP-1 signaling ameliorates hedgehog-induced fibroblast activation and skin fibrosis in SmoACT mice with a reduction of skin thickness of 103% (P = 0.0043) in the treatment group compared to the fibrotic control group. Moreover, combined pharmacologic inhibition of cJUN/AP-1 and hedgehog/GLI2 exerts additive antifibrotic effects in a model of TGFβ-driven experimental fibrosis (TBRACT mice). CONCLUSION: The transcription factors cJUN and GLI2 reinforce each other's activity to promote fibroblast activation in SSc. Interruption of this crosstalk by combined inhibition of both pathways exerts additive antifibrotic effects at well-tolerated doses.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Bergmann C, Chenguiti Fakhouri S, Trinh-Minh T, et al. Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies. Arthritis Rheumatol. 2024. PMID: 39187464. doi:10.1002/art.42979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。